Karsten U - Search Results

1

PankoMab: a potent new generation anti-tumour MUC1 antibody.

Danielczyk A, Stahn R, Faulstich D, Löffler A, Märten A, Karsten U, Goletz S. Danielczyk A, et al. Among authors: karsten u. Cancer Immunol Immunother. 2006 Nov;55(11):1337-47. doi: 10.1007/s00262-006-0135-9. Epub 2006 Feb 17. Cancer Immunol Immunother. 2006. PMID: 16485130 Free PMC article.

2

What makes MUC1 a tumor antigen?

Karsten U, von Mensdorff-Pouilly S, Goletz S. Karsten U, et al. Tumour Biol. 2005 Jul-Aug;26(4):217-20. doi: 10.1159/000086956. Epub 2005 Jul 6. Tumour Biol. 2005. PMID: 16006776 Review.

3

The Thomsen-Friedenreich disaccharide as antigen for in vivo tumor targeting with multivalent scFvs.

Ravn P, Stahn R, Danielczyk A, Faulstich D, Karsten U, Goletz S. Ravn P, et al. Among authors: karsten u. Cancer Immunol Immunother. 2007 Sep;56(9):1345-57. doi: 10.1007/s00262-007-0292-5. Epub 2007 Feb 20. Cancer Immunol Immunother. 2007. PMID: 17310382 Free PMC article.

4

Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6.

Ulsemer P, Henderson G, Toutounian K, Löffler A, Schmidt J, Karsten U, Blaut M, Goletz S. Ulsemer P, et al. Among authors: karsten u. Cancer Immunol Immunother. 2013 May;62(5):875-87. doi: 10.1007/s00262-013-1394-x. Epub 2013 Feb 5. Cancer Immunol Immunother. 2013. PMID: 23381581 Free PMC article.

5

A monoclonal antibody to Lewis Y/Lewis b revealing mimicry of the histone H1 to carbohydrate structures.

Christensen PA, Danielczyk A, Ravn P, Stahn R, Karsten U, Goletz S. Christensen PA, et al. Among authors: karsten u. Scand J Immunol. 2007 Apr;65(4):362-7. doi: 10.1111/j.1365-3083.2007.01913.x. Scand J Immunol. 2007. PMID: 17386027 Free article.

6

Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1).

Karsten U, Serttas N, Paulsen H, Danielczyk A, Goletz S. Karsten U, et al. Glycobiology. 2004 Aug;14(8):681-92. doi: 10.1093/glycob/cwh090. Epub 2004 Apr 28. Glycobiology. 2004. PMID: 15115750

7

Multivalent scFv display of phagemid repertoires for the selection of carbohydrate-specific antibodies and its application to the Thomsen-Friedenreich antigen.

Ravn P, Danielczyk A, Jensen KB, Kristensen P, Christensen PA, Larsen M, Karsten U, Goletz S. Ravn P, et al. Among authors: karsten u. J Mol Biol. 2004 Oct 29;343(4):985-96. doi: 10.1016/j.jmb.2004.08.052. J Mol Biol. 2004. PMID: 15476815

8

Reactivity of a humanized antibody (hPankoMab) towards a tumor-related MUC1 epitope (TA-MUC1) with various human carcinomas.

Fan XN, Karsten U, Goletz S, Cao Y. Fan XN, et al. Among authors: karsten u. Pathol Res Pract. 2010 Aug 15;206(8):585-9. doi: 10.1016/j.prp.2010.03.006. Epub 2010 Apr 18. Pathol Res Pract. 2010. PMID: 20400237

9

What makes cancer stem cell markers different?

Karsten U, Goletz S. Karsten U, et al. Springerplus. 2013 Jul 4;2(1):301. doi: 10.1186/2193-1801-2-301. Print 2013 Dec. Springerplus. 2013. PMID: 23888272 Free PMC article.

10

Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients.

Heublein S, Mayr D, Egger M, Karsten U, Goletz S, Angele M, Gallwas J, Jeschke U, Ditsch N. Heublein S, et al. Among authors: karsten u. J Exp Clin Cancer Res. 2015 May 19;34(1):50. doi: 10.1186/s13046-015-0152-7. J Exp Clin Cancer Res. 2015. PMID: 25986064 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

252 results

Search Page